Pharma Journalist - Page 70 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Sutro Biopharma Partners with FDA to Advance Antibody Drug Conjugate Regulatory Standards

Sanofi to Acquire Vicebio, Boosting Respiratory Vaccine Portfolio

ProMIS Neurosciences Receives FDA Fast Track Designation for PMN310 Alzheimer’s Treatment

AusperBio Secures China CDE Clearance to Launch Phase III Trial for AHB-137 in Chronic Hepatitis B

Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S.

J&J Seeks First FDA Approval for Icotrokinra to Treat Plaque Psoriasis

AstraZeneca to Invest $50 Billion in U.S. for Drug Manufacturing and R&D

Rocket Pharma’s RP-A601 Gene Therapy Granted FDA RMAT Designation for PKP2-ACM

Aldeyra’s Dry Eye Drug NDA Accepted for FDA Review

Astellas Partners with Korea’s KISED to Support Drug-Discovery Startups